Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Oct;52(10):2646–2655. doi: 10.1172/JCI107457

The Effects of Colestipol Resin and of Colestipol Plus Clofibrate on the Turnover of Plasma Cholesterol in Man

DeWitt S Goodman 1,2,3, Robert P Noble 1,2,3, Ralph B Dell 1,2,3
PMCID: PMC302525  PMID: 4729058

Abstract

Studies were conducted to determine the effects of colestipol hydrochloride, a new bile acid-sequestrant resin, on some of the parameters of cholesterol turnover and metabolism in man. Three normal volunteers and eight hyperlipidemic patients participated in three sets of cholesterol turnover studies carried out at intervals of approximately 1 yr. The effects of colestipol were assessed by comparing the results obtained before therapy with those obtained on repeat study after several months of resin therapy. Colestipol treatment significantly reduced the serum cholesterol concentration (mean reduction 21%), and produced a large increase in the production rate of cholesterol (mean 86%) and in the turnover rate of cholesterol in pool 1 (mean 46%). The values of the intercompartmental rate constants and of the size of the rapidly exchangeable pool were unchanged with therapy.

The turnover studies were carried out for 12-13 wk, and were analyzed according to a two-pool model. Although long-term studies of cholesterol turnover conform to a three-pool, rather than a two-pool model, the present studies probably provide a valid estimate of the effects of therapy on certain parameters, namely the production rate, the size, and the turnover rate of pool 1.

Repeated studies in four untreated subjects showed a striking constancy with time for the kinetic parameters for each subject. The production rate was particularly constant from year to year for a given subject, and showed a pooled standard deviation of only 3%. The findings suggest that the total body turnover of cholesterol is under close homeostatic control in an integrated manner.

Combined drug therapy with colestipol plus clofibrate further reduced the serum cholesterol level in three of four patients, and reduced the triglyceride level in all four patients. Addition of clofibrate to the treatment program produced only small decreases in the production rate, which were not significantly different from the small decreases seen in two patients who were continued (and restudied) on colestipol alone. The findings do not support the suggestion that clofibrate can block the increased rate of cholesterol synthesis and turnover resulting from bile acid-sequestrant treatment. The effects on serum lipids, however, make the combined drug therapy potentially quite useful.

Full text

PDF
2646

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVOY D. R., SWYRYD E. A., GOULD R. G. EFFECTS OF ALPHA-P-CHLOROPHENOXYISOBUTYRYL ETHYL ESTER (CPIB) WITH AND WITHOUT ANDROSTERONE ON CHOLESTEROL BIOSYNTHESIS IN RAT LIVER. J Lipid Res. 1965 Jul;6:369–376. [PubMed] [Google Scholar]
  2. BHATTATHIRY E. P., SHIPERSTEIN M. D. FEEDBACK CONTROL OF CHOLESTEROL SYNTHESIS IN MAN. J Clin Invest. 1963 Oct;42:1613–1618. doi: 10.1172/JCI104846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
  4. Bierman E. L., Brunzell J. D., Bagdade J. D., Lerner R. L., Hazzard W. R., Porte D., Jr On the mechanism of action of atromid-S on triglyceride transport in man. Trans Assoc Am Physicians. 1970;83:211–224. [PubMed] [Google Scholar]
  5. Carlson L. A., Böttiger L. E. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet. 1972 Apr 22;1(7756):865–868. doi: 10.1016/s0140-6736(72)90738-6. [DOI] [PubMed] [Google Scholar]
  6. Cayen M. N., Dvornik D. Agents affecting lipid metabolism. XXXIX. Effect of combined administration of ethyl chlorophenoxyisobutyrate and cholestyramine on cholesterol biosynthesis in the rat. Can J Biochem. 1970 Sep;48(9):1022–1023. doi: 10.1139/o70-160. [DOI] [PubMed] [Google Scholar]
  7. Dietschy J. M. The role of bile salts in controlling the rate of intestinal cholesterogenesis. J Clin Invest. 1968 Feb;47(2):286–300. doi: 10.1172/JCI105725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dietschy J. M., Wilson J. D. Regulation of cholesterol metabolism. I. N Engl J Med. 1970 May 14;282(20):1128–1138. doi: 10.1056/NEJM197005142822005. [DOI] [PubMed] [Google Scholar]
  9. Fallon H. J., Woods J. W. Response of hyperlipoproteinemia to cholestyramine resin. JAMA. 1968 Jun 24;204(13):1161–1164. [PubMed] [Google Scholar]
  10. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 19;276(3):148–contd. doi: 10.1056/NEJM196701192760305. [DOI] [PubMed] [Google Scholar]
  11. Glueck C. J., Ford S., Jr, Scheel D., Steiner P. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia. JAMA. 1972 Nov 6;222(6):676–681. doi: 10.1001/jama.222.6.676. [DOI] [PubMed] [Google Scholar]
  12. Goodman D. S., Noble R. P., Dell R. B. Three-pool model of the long-term turnover of plasma cholesterol in man. J Lipid Res. 1973 Mar;14(2):178–188. [PubMed] [Google Scholar]
  13. Goodman D. S., Noble R. P. Turnover of plasma cholesterol in man. J Clin Invest. 1968 Feb;47(2):231–241. doi: 10.1172/JCI105719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Grundy S. M., Ahrens E. H., Jr Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods. J Lipid Res. 1969 Jan;10(1):91–107. [PubMed] [Google Scholar]
  15. Grundy S. M., Ahrens E. H., Jr, Salen G. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med. 1971 Jul;78(1):94–121. [PubMed] [Google Scholar]
  16. Grundy S. M., Ahrens E. H., Jr, Salen G., Schreibman P. H., Nestel P. J. Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. J Lipid Res. 1972 Jul;13(4):531–551. [PubMed] [Google Scholar]
  17. HASHIM S. A., VANITALLIE T. B. CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES. JAMA. 1965 Apr 26;192:289–293. doi: 10.1001/jama.1965.03080170017004. [DOI] [PubMed] [Google Scholar]
  18. HUFF J. W., GILFILLAN J. L., HUNT V. M. EFFECT OF CHOLESTYRAMINE, A BILE ACID-BINDING POLYMER ON PLASMA CHOLESTEROL AND FECAL BILE ACID EXCRETION IN THE RAT. Proc Soc Exp Biol Med. 1963 Nov;114:352–355. doi: 10.3181/00379727-114-28674. [DOI] [PubMed] [Google Scholar]
  19. Horlick L., Kudchodkar B. J., Sodhi H. S. Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man. Circulation. 1971 Feb;43(2):299–309. doi: 10.1161/01.cir.43.2.299. [DOI] [PubMed] [Google Scholar]
  20. Howard A. N., Hyams D. E., Evans C. The combined use of clofibrate and anion exchange in the treatment of hypercholesterolemia. Adv Exp Med Biol. 1972;26(0):179–187. doi: 10.1007/978-1-4684-7547-0_15. [DOI] [PubMed] [Google Scholar]
  21. Jones R. J., Dobrilovic L. Lipoprotein lipid alterations with cholestyramine administration. J Lab Clin Med. 1970 Jun;75(6):953–966. [PubMed] [Google Scholar]
  22. Moore R. B., Crane C. A., Frantz I. D., Jr Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patient. J Clin Invest. 1968 Jul;47(7):1664–1671. doi: 10.1172/JCI105857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Moore R. B., Frantz I. D., Jr, Buchwald H. Changes in cholesterol pool size, turnover rate, and fecal bile acid and sterol excretion after partial ileal bypass in hypercholesteremic patients. Surgery. 1969 Jan;65(1):98–108. [PubMed] [Google Scholar]
  24. Moutafis C. D., Myant N. B. The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine. Clin Sci. 1969 Oct;37(2):443–454. [PubMed] [Google Scholar]
  25. NESTEL P. J., HIRSCH E. Z., COUZENS E. A. THE EFFECT OF CHLOROPHENOXYISOBUTYRIC ACID AND ETHINYL ESTRADIOL ON CHOLESTEROL TURNOVER. J Clin Invest. 1965 Jun;44:891–896. doi: 10.1172/JCI105205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nestel P. J., Whyte H. M., Goodman D. S. Distribution and turnover of cholesterol in humans. J Clin Invest. 1969 Jun;48(6):982–991. doi: 10.1172/JCI106079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Noble R. P. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968 Nov;9(6):693–700. [PubMed] [Google Scholar]
  28. Nye E. R., Jackson D., Hunter J. D. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent. N Z Med J. 1972 Jul;76(482):12–16. [PubMed] [Google Scholar]
  29. Parkinson T. M., Gundersen K., Nelson N. A. Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and man. Atherosclerosis. 1970 May-Jun;11(3):531–537. doi: 10.1016/0021-9150(70)90030-4. [DOI] [PubMed] [Google Scholar]
  30. Ryan J. R., Jain A. The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study. J Clin Pharmacol New Drugs. 1972 Jul;12(7):268–273. doi: 10.1002/j.1552-4604.1972.tb00054.x. [DOI] [PubMed] [Google Scholar]
  31. Samuel P., Holtzman C. H., Meilman E., Perl W. Effect of neomycin on exchangeable pools of cholesterol in the steady state. J Clin Invest. 1968 Aug;47(8):1806–1818. doi: 10.1172/JCI105870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Samuel P., Lieberman S. Improved estimation of body masses and turnover of cholesterol by computerized input--output analysis. J Lipid Res. 1973 Mar;14(2):189–196. [PubMed] [Google Scholar]
  33. Samuel P., Perl W. Long-term decay of serum cholesterol radioactivity: body cholesterol metabolism in normals and in patients with hyperlipoproteinemia and atherosclerosis. J Clin Invest. 1970 Feb;49(2):346–357. doi: 10.1172/JCI106243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schneider D. L., Gallo D. G., Sarett H. P. Effect of cholestyramine on cholesterol metabolism in young adult swine. Proc Soc Exp Biol Med. 1966 Apr;121(4):1244–1248. doi: 10.3181/00379727-121-31018. [DOI] [PubMed] [Google Scholar]
  35. Shefer S., Hauser S., Bekersky I., Mosbach E. H. Biochemical site of regulation of bile acid biosynthesis in the rat. J Lipid Res. 1970 Sep;11(5):404–411. [PubMed] [Google Scholar]
  36. Shefer S., Hauser S., Bekersky I., Mosbach E. H. Feedback regulation of bile acid biosynthesis in the rat. J Lipid Res. 1969 Nov;10(6):646–655. [PubMed] [Google Scholar]
  37. Strisower E. H., Adamson G., Strisower B. Treatment of hyperlipidemias. Am J Med. 1968 Oct;45(4):488–501. doi: 10.1016/0002-9343(68)90165-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES